Saad Z. Usmani, Michał Mielnik, Aránzazu Alonso, Al-Ola A. Abdallah, Mamta Garg, Wojciech Janowski, Youngil Koh, Enrique M. Ocio, Hang Quach, Karthik Ramasamy, Albert Oriol Rocafiguera, Paula Rodriguez-Otero, Irwindeep Sandhu, Katja C. Weisel, Chris Brawley, Miguel Murillo, Farrah Pompilus, Jacqueline L. Egger, Morrys C. Kaisermann, Marek Hus. "DREAMM-9 final analysis: Belantamab mafodotin (belamaf), bortezomib, lenalidomide, and dexamethasone (BVRd) for transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7503